NewMarket Just Raised Its Dividend 8.3%. Here Are 2 More Under-the-Radar Dividend Stocks

Stepan, NewMarket and Leidos each raised quarterly dividends: 2.5% to $0.405, 8.3% to $3.25 and 4.7% to $0.45 per share, respectively. The article highlights earnings and cash-flow coverage, including Leidos’s $761 million of second-quarter free cash flow versus $55 million in dividends, while noting risks such as Stepan’s weak quarterly free-cash-flow coverage, falling NewMarket additive shipments and Leidos’s roughly $6.0 billion in debt. Share performance was mixed: NewMarket fell 9.99% over the past week, while Leidos gained 17.36% over the past month.

Analysis

The dividend increases are weak evidence of improving operating momentum; the more useful signal is whether cash conversion and underlying volumes confirm earnings. SCL’s near-term setup is asymmetric: working-capital absorption has already put quarterly free cash flow below the payout, so another weak conversion quarter could overwhelm the reassuring adjusted-earnings narrative. The land-sale proceeds help leverage, but are not recurring cash generation. Treat SCL as a cash-conversion watch, not a dividend-growth momentum buy.

NEU’s payout capacity is not the key debate; durability of the core additives franchise is. Falling shipment volume masked by surcharges leaves earnings exposed if volumes do not stabilize, while Specialty Materials capacity and acquisition-driven growth offer a partial offset—not yet proof of a company-wide reacceleration. The recent share weakness despite the raise suggests investors are focused on that distinction.

LDOS has the clearest potential rerating path if contract execution and cash generation hold, but acquisition-related debt makes capital allocation consequential: buybacks compete with deleveraging, and a large backlog is not equivalent to near-term margin or cash realization. The upcoming results are the near-term catalyst; a dividend raise alone should not justify chasing the recent rebound. Over 6–18 months, defense demand supports visibility, while budget timing, recompetes, and integration execution can reverse the thesis. The contrarian angle: headline payout safety may be overvalued relative to cash-flow quality at SCL and volume health at NEU; for LDOS, the low stated forward multiple may be compensation for leverage and execution risk rather than a free rerating.

Key Decisions for Investors

• LDOS: Prefer a staged long only after the next earnings release confirms free-cash-flow conversion and a credible debt-reduction path; avoid adding ahead of the event. Reassess if cash conversion weakens materially, leverage stops declining, or contract execution/backlog conversion disappoints.
• SCL: Keep on a watchlist rather than buying for the dividend. Require positive full-year free cash flow and evidence working capital is normalizing; a second period of payout-unsupported cash flow would falsify the safety thesis.
• NEU: Do not chase the dividend increase. Monitor Petroleum Additives shipment volumes separately from surcharge-supported revenue and confirm new Specialty Materials capacity is contributing organically; continued volume declines without offsetting earnings growth would argue for avoiding or reducing exposure.
• Across all three, treat dividend growth as a capital-allocation signal, not a standalone catalyst. The key near-term checks are SCL cash conversion, NEU core shipment trends, and LDOS post-acquisition cash flow, leverage, and buyback-versus-debt priorities.